Trial Profile
A Phase III, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of 14 Day Treatment With Lansoprazole 15 mg Once a Day in Frequent Heartburn
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 02 Jun 2010
Price :
$35
*
At a glance
- Drugs Lansoprazole (Primary)
- Indications Heartburn
- Focus Therapeutic Use
- Sponsors Novartis
- 01 Jul 2009 Results have been reported in Postgraduate Medicine.
- 18 May 2007 Status change
- 12 Jan 2007 Status change